BioCentury
ARTICLE | Clinical News

Belbuca buprenorphine buccal film regulatory update

March 16, 2015 7:00 AM UTC

BioDelivery and Endo said FDA accepted for review an NDA for Belbuca buprenorphine buccal film to manage pain severe enough to require daily, around-the-clock, long-term opioid treatment for which alt...